For the first time ever, an AIDS vaccine has protected subjects of a clinical trial from infection. Now directors of a new Seattle-based study are hoping for a repeat performance -- or maybe even a cure.
AIDS study hopes to build on trial's successCourtesy Seattle Post-Intelligencer: Health and Fitness Thu, 09/24/2009 - 22:57
For the first time ever, an AIDS vaccine has protected subjects of a clinical trial from infection. Now directors of a new Seattle-based study are hoping for a repeat performance -- or maybe even a cure. More related itemsFull results show AIDS vaccine is of modest help
Trial: AIDS Vaccine Reduces Risk of HIV Infection
AIDS Vaccine Experiment Yields Unanticipated Results
The Unwritten Rules of Friendship: Simple Strategies...
|
Popular by tags WeekMonth |
Post new comment